DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC ASPECTS OF EOSINOPHILIC ESOPHAGITIS IN CHILDREN AGED 1-11 YEARS IN THE PHASE 3 EOE KIDS TRIAL

被引:0
|
作者
Chehade, Mirna
Dellon, Evan S.
Spergel, Jonathan
Rothenberg, Marc E.
Liu, Ruiqi
Mannent, Leda
Laws, Elizabeth
Mortensen, Eric
Maloney, Jennifer
Khokhar, Faisel
Beazley, Bethany
Glotfelty, Lila
Shabbir, Arsalan
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
605
引用
收藏
页码:S112 / S112
页数:1
相关论文
共 48 条
  • [1] DUPILUMAB IMPROVES HISTOLOGIC AND ENDOSCOPIC OUTCOMES IN CHILDREN AGED 1 TO <12 YEARS WITH EOSINOPHILIC ESOPHAGITIS (EOE): 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
    Chehade, Mirna
    Dellon, Evan S.
    Spergel, Jonathan
    Rothenberg, Marc E.
    Pesek, Robert
    Collins, Margaret H.
    Hirano, Ikuo
    Liu, Ruiqi
    Laws, Elizabeth
    Mortensen, Eric R.
    Abdulai, Raolat M.
    Maloney, Jennifer
    McCann, Eilish
    Kosloski, Matthew
    Hamilton, Jennifer D.
    Samuely, Carin
    Glotfelty, Lila
    Shabbir, Arsalan
    GASTROENTEROLOGY, 2024, 166 (05) : S402 - S402
  • [2] Dupilumab Improves Histologic And Endoscopic Outcomes In Children Aged 1 To &lt;<12 Years With Eosinophilic Esophagitis (EoE): 52-Week Results From The Phase 3 EoE KIDS Trial
    Chehade, Mirna
    Dellon, Evan
    Spergel, Jonathan
    Rothenberg, Marc
    Pesek, Robert
    Collins, Margaret
    Hirano, Ikuo
    Liu, Ruiqi
    Laws, Elizabeth
    Mortensen, Eric
    Martincova, Renata
    Maloney, Jennifer
    McCann, Eilish
    Kosloski, Matthew
    Hamilton, Jennifer
    Samuely, Carin
    Glotfelty, Lila
    Shabbir, Arsalan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB266 - AB266
  • [3] Dupilumab improves histologic and endoscopic aspects of eosinophilic esophagitis (EoE), as well as rate of weight gain, in children aged 1 to < 12 years: 52-week results from the Phase 3 EoE KIDS trial
    von Arnim, Ulrike
    Chehade, Mirna
    Dellon, Evan S.
    Spergel, Jonathan M.
    Rothenberg, Marc E.
    Pesek, Robert D.
    Collins, Margaret H.
    Hirano, Ikuo
    Liu, Ruiqi
    Laws, Elizabeth
    Mortensen, Eric
    Abdulai, Raolat M.
    Maloney, Jennifer
    McCann, Eilish
    Kosloski, Matthew P.
    Hamilton, Jennifer D.
    Samuely, Carin
    Glotfelty, Lila
    Shabbir, Arsalan
    INNERE MEDIZIN, 2024, 65 : S38 - S38
  • [4] Dupilumab Normalized The Expression Of Genes Dysregulated In Eosinophilic Esophagitis (EoE) In Esophageal Biopsies From A Clinical Trial Of Children Aged 1-11 Years
    Rothenberg, Marc
    Lim, Wei Keat
    Wipperman, Matthew
    Chehade, Mirna
    Dellon, Evan
    Hundal, Navneet Virk
    Schroeder, Shauna
    Parrish, Christopher
    Liu, Ruiqi
    Laws, Elizabeth
    Mortensen, Eric
    Glotfelty, Lila
    Shabbir, Arsalan
    Hicks, Alexandra
    Hamilton, Jennifer
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB147 - AB147
  • [5] DUPILUMAB IMPROVES ESOPHAGEAL FEATURES OF EOSINOPHILIC ESOPHAGITIS (EOE) AS MEASURED BY ENDOSCOPIC REFERENCE SCORE IN CHILDREN WITH EOE: 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
    Hirano, Ikuo
    Schroeder, Shauna R.
    Chehade, Mirna
    Menard-Katcher, Calies D.
    Hundal, Navneet Virk
    Liu, Ruiqi
    Abdulai, Raolat M.
    Maloney, Jennifer
    Glotfelty, Lila
    Shabbir, Arsalan
    GASTROENTEROLOGY, 2024, 166 (05) : S401 - S402
  • [6] DUPILUMAB IMPROVES HISTOPATHOLOGIC ENDPOINTS IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
    Collins, Margaret H.
    Rothenberg, Marc E.
    Lerner, Diana G.
    Pesek, Robert
    Hundal, Navneet Virk
    Liu, Ruiqi
    Maloney, Jennifer
    Abdulai, Raolat M.
    Glotfelty, Lila
    Shabbir, Arsalan
    GASTROENTEROLOGY, 2024, 166 (05) : S402 - S402
  • [7] Dupilumab Improves Multiple Histopathologic Endpoints in Children With Eosinophilic Esophagitis: 52-Week Results From the Phase 3 EoE KIDS Trial
    Collins, Margaret H.
    Rothenberg, Marc E.
    Lerner, Diana
    Pesek, Robert D.
    Hundal, Navneet Virk
    Liu, Ruiqi
    Maloney, Jennifer
    Abdulai, Raolat M.
    Louisias, Margee
    Radin, Allen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S456 - S457
  • [8] DUPILUMAB IMPROVES DISEASE SEVERITY AND QUALITY OF LIFE IN CHILDREN WITH EOSINOPHILIC ESOPHAGITIS: 52-WEEK RESULTS FROM THE PHASE 3 EOE KIDS TRIAL
    Dellon, Evan S.
    Oliva, Salvatore
    Ashok, Dhandapani
    Liu, Ruiqi
    Glotfelty, Lila
    Shabbir, Arsalan
    Tilton, Sarette T.
    Ge, Wenzhen
    GASTROENTEROLOGY, 2024, 166 (05) : S401 - S401
  • [9] DUPILUMAB IMPROVES CLINICAL, SYMPTOMATIC, HISTOLOGIC, ENDOSCOPIC ASPECTS OF EOE: POOLED RESULTS FROM PHASE 3 LIBERTY-EOE-TREET
    Dellon, E.
    Rothenberg, M.
    Hirano, I.
    Bredenoord, A.
    Lucendo, A.
    Sun, X.
    Patel, K.
    Beazley, B.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S25 - S25
  • [10] DUPILUMAB IMPROVES INFLAMMATORY AND REMODELING ASPECTS OF ENDOSCOPIC DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE PHASE 3 LIBERTY-EOE-TREET STUDY
    Hirano, Ikuo
    Collins, Margaret H.
    Dellon, Evan S.
    Sun, Xian
    Beazley, Bethany
    Glotfelty, Lila
    Shabbir, Arsalan
    Giannelou, Angeliki
    GASTROENTEROLOGY, 2023, 164 (06) : S346 - S346